Hemophilia News and Research

RSS
Hemophilia is a rare, inherited bleeding disorder in which your blood doesn’t clot normally. If you have hemophilia, you may bleed for a longer time than others after an injury. You also may bleed internally, especially in your knees, ankles, and elbows. This bleeding can damage your organs or tissues and, sometimes, be fatal.
In Massachusetts, proposed Medicaid cuts put kids’ health care at risk

In Massachusetts, proposed Medicaid cuts put kids’ health care at risk

Novel therapy decreases incidence of bleeding by 87% in hemophilia A patients with inhibitors

Novel therapy decreases incidence of bleeding by 87% in hemophilia A patients with inhibitors

Abbott introduces Sekisui CP3000 fully automated coagulation system for accurate test results

Abbott introduces Sekisui CP3000 fully automated coagulation system for accurate test results

International team to set how gene therapies in hemophilia should be measured for effectiveness

International team to set how gene therapies in hemophilia should be measured for effectiveness

TSRI scientist and partners receive $7.2 million grant to create new RNA-based treatments for ALS

TSRI scientist and partners receive $7.2 million grant to create new RNA-based treatments for ALS

Altered virus could help more patients to become eligible for human gene therapy trials

Altered virus could help more patients to become eligible for human gene therapy trials

TSRI scientists solve cellular mystery that may have implications for fundamental biology

TSRI scientists solve cellular mystery that may have implications for fundamental biology

Anti-heroin vaccine developed at TSRI proven effective in primate models

Anti-heroin vaccine developed at TSRI proven effective in primate models

TSRI study reveals first-ever structure of Lassa virus protein

TSRI study reveals first-ever structure of Lassa virus protein

TSRI professor receives $2 million grant to study neurofibromatosis type I

TSRI professor receives $2 million grant to study neurofibromatosis type I

TSRI scientists give new superpowers to lifesaving antibiotic

TSRI scientists give new superpowers to lifesaving antibiotic

Scripps scientists make important advance in HIV vaccine design

Scripps scientists make important advance in HIV vaccine design

TSRI scientists discover potential new therapy to stop deadly botulinum neurotoxin

TSRI scientists discover potential new therapy to stop deadly botulinum neurotoxin

Researchers uncover structural details that make eye-targeting virus a better tool for future therapies

Researchers uncover structural details that make eye-targeting virus a better tool for future therapies

Sangamo Therapeutics and Pfizer team up for development of Hemophilia A gene therapy

Sangamo Therapeutics and Pfizer team up for development of Hemophilia A gene therapy

Three TSRI scientists receive awards from Royal Society of Chemistry

Three TSRI scientists receive awards from Royal Society of Chemistry

TSRI scientists reveal important role of genetics in brain circuits

TSRI scientists reveal important role of genetics in brain circuits

Novo Nordisk introduces new web-based portal that helps patients track their hemophilia treatment

Novo Nordisk introduces new web-based portal that helps patients track their hemophilia treatment

TSRI study could lead to personalized treatments for alcohol dependence

TSRI study could lead to personalized treatments for alcohol dependence

TSRI scientists find new way to make cell population resistant to HIV

TSRI scientists find new way to make cell population resistant to HIV